<ClinicalUseDefinition xmlns="http://hl7.org/fhir"><id value="example-interaction"/><extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"><valueCode value="brr"/></extension><type value="interaction"/><subject><reference><reference value="MedicinalProductDefinition/example"/></reference></subject><interaction><interactant><itemCodeableConcept><coding><system value="http://ema.europa.eu/example/interactant"/><code value="alphaconazole"/></coding></itemCodeableConcept></interactant><interactant><itemCodeableConcept><coding><system value="http://ema.europa.eu/example/interactant"/><code value="betaconazole"/></coding></itemCodeableConcept></interactant><type><coding><system value="http://ema.europa.eu/example/interactionsType"/><code value="Inhibitor"/></coding></type><effect><concept><text value="Increased plasma concentration"/></concept></effect><management><text value="Careful monitoring of dose"/></management></interaction></ClinicalUseDefinition>